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Diabetes and the development of its complications have been
associated with mitochondrial DNA (mtDNA) dysfunction, but
causal relationships remain undetermined. With the objective of
testing whether increased mtDNA mutations exacerbate the di-
abetic phenotype, we have compared mice heterozygous for the
Akita diabetogenic mutation (Akita) with mice homozygous for the
D257A mutation in mitochondrial DNA polymerase gamma (Polg)
or with mice having both mutations (Polg-Akita). The Polg-D257A
protein is defective in proofreading and increases mtDNA muta-
tions. At 3 mo of age, the Polg-Akita and Akita male mice were
equally hyperglycemic. Unexpectedly, as the Polg-Akita males aged
to 9 mo, their diabetic symptoms decreased. Thus, their hypergly-
cemia, hyperphagia and urine output declined significantly. The
decrease in their food intakewas accompanied by increased plasma
leptin and decreased plasma ghrelin, while hypothalamic expres-
sion of the orexic gene, neuropeptide Y, was lower and expression
of the anorexic gene, proopiomelanocortin, was higher. Testis func-
tion progressively worsened with age in the double mutants, and
plasma testosterone levels in 9-mo-old Polg-Akita males were
significantly reduced compared with Akita males. The hyperglyce-
mia and hyperphagia returned in aged Polg-Akita males after
testosterone administration. Hyperglycemia-associated distal tu-
bular damage in the kidney also returned, and Polg-D257A-associated
proximal tubular damage was enhanced. The mild diabetes of
female Akita mice was not affected by the Polg-D257A mutation.
We conclude that reduced diabetic symptoms of aging Polg-Akita
males results from appetite suppression triggered by decreased
testosterone associatedwith damage to the Leydig cells of the testis.
Diabetes mellitus is becoming increasingly common world-wide. A large body of data demonstrates links between mi-
tochondrial dysfunction, insulin resistance, and diabetes (1, 2).
Deleterious mitochondrial DNA (mtDNA) mutations have their
greatest effect in cells that require high energy production, or
already have high oxidative stress, including neurons, hair cells of
the inner ears, heart and skeletal myocytes, pancreatic beta cells,
and gut and kidney epithelial cells (3–7). Complications of di-
abetes also involve damage to these metabolically active cell
types, leading to a hypothesis that mtDNA mutations contributes
to the complications. Consistent with these findings, we have
demonstrated in mice that a genetic absence of the bradykinin B2
receptor (B2R) combined with diabetes caused by the Akita mu-
tation, Ins2C96Y, progressively increases modifications to kidney
mtDNA, including 8-hydroxy-2′-deoxyguanosine content, point
mutations, and deletions (8, 9). The mtDNA mutations in these
mice are also associated with enhanced nephropathy and senes-
cence-related phenotypes in multiple tissues (8, 9). However, it
remains unclear whether the mtDNA mutations act causally with
respect to diabetes and its complications, or are consequences of
these conditions.
The enzymes required for mitochondrial biogenesis are enco-
ded in the nuclear genome, including mtDNA polymerase γ
(Polg), which replicates and proofreads the mitochondrial ge-
nome. Polg is essential for life, and its complete absence leads to
early embryonic death (10). An amino acid substitution, D257A,
in the exonuclease domain II of Polg ablates proofreading without
significantly affecting the capacity of the polymerase to replicate
mtDNA (11, 12). Mice homozygous for the D257A mutation
(Polg) die prematurely by 13 mo of age, displaying a series of
aging-associated phenotypes due to increased random accumu-
lations of mtDNA mutations that lead to increased apoptosis,
particularly in tissues containing cells that are metabolically active
(11, 12). The D257A mutation, which does not itself induce di-
abetes, consequently provides a tool that can be used to determine
whether an increased frequency of mtDNA mutations can in-
fluence the pathophysiology of diabetes and its complications.
In the present work, we take advantage of this tool to examine
the effects of the Polg-D257A mutation in mice that are diabetic
because of the dominant Akita mutation (C96Y) in the Ins2 gene.
The C96Y mutation prevents the formation of an important
disulfide bond in insulin and leads to misfolding of the protein.
The misfolded protein has impaired transport through the en-
doplasmic reticulum (ER), which triggers an ER stress reaction
leading to pancreatic β-cell apoptosis (13). Males heterozygous
for the Akita mutation, but not females, develop hyperglycemia
begining at ≈3 wk of age and becoming progressively more severe
with age. Surprisingly, our experiments show that the diabetic
symptoms of Akita male mice, which also have the PolgD257A
mutation (Polg-Akita), become progressively less severe after
3 mo of age. We demonstrate that the overall improvement in the
diabetic phenotype of the Polg-Akita mice is at least in part due
to a reduction in the Akita-induced hyperphagia triggered by
a Polg-induced decrease in testis production of testosterone.
Glomerular changes were mild in all of the diabetic mice. Prox-
imal tubular damage occurred only in aged double mutant males.
Distal tubular damage occurred in all hyperglycemic males.
Results
Mitochondrial Mutations in Polg-Akita Mice. The reported median
lifespan of Polg mice homozygous for Polg-D275A mutation is
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13 mo, and the amount of mtDNA mutations accumulating in
Polg mice has been estimated to be as high as 1 × 10−3 mutations
per bp in most tissues compared with <5 × 10−4 mutations per bp
in wild-type mice (11, 12, 14, 15). Because untreated Akita di-
abetic mice deteriorate quickly after 9 mo (16), we determined
mtDNA mutation load in the liver of 9-mo-old mice, which are
histologically intact at this age. As expected, the average number
of base substitution per site per hundred mtDNA molecules,
without correcting for errors associated with deep sequencing
and heteroplasmic polymorphisms, was significantly higher in the
Polg mice than in their wild-type (WT) littermates (0.425 ± 0.005
mutations per site per hundred molecules sequenced vs. 0.375 ±
0.004; P ≤ 0.001). Diabetes, again as expected, further increased
base substitution rate (P < 0.001), with the Polg-Akita mice
having significantly more mutations than their Akita littermates
(0.557 ± 0.007 vs. 0.494 ± 0.008; P ≤ 0.001). We conclude that
the mtDNA of 9-mo-old Polg-Akita mice has accumulated sig-
nificantly more mutations than the mtDNA of their Akita siblings.
The expressions of mitochondrial transcription factor A
(Tfam), mtDNA polymerase γ (Polg), and cytochrome b (CytB)
have been correlated, respectively, with mitochondrial biogenesis
(17), replication (18), and function (19). However, renal and
hepatic gene expression of Tfam, Polg, and CytB did not differ
significantly among the groups (Table S1). Similarly, mtDNA
content in these tissues was not significantly different between
the two genotypes (Fig. S1). We conclude that the Polg mutation
did not change mitochondrial biogenesis and replication in our
diabetic mice.
mtDNA damage associated with diabetes also includes an
increased incidence of deletions (8, 9). However, we found no
significant differences in the incidence of D-17 deletions in the
liver, pancreas, kidneys, and small intestine of the Polg-Akita
mice compared with the Akita mice (Fig. S1).
Improved Diabetic Symptoms in Aging Male Polg-Akita Mice. At
3 mo of age, both Akita and Polg-Akita male mice exhibited all
of the symptoms normally associated with type 1 diabetes. Thus,
both had markedly elevated plasma glucose levels (491 ± 33 mg/
dL; Fig. 1A) and food intake (8.5 g/d; Fig. 1B) compared with
their nondiabetic counterparts. In contrast, at 6 mo of age,
plasma glucose and food consumption in the Polg-Akita mice
began to show significant decreases relative to the Akita mice. By
9 mo of age, the fasting plasma glucose levels in the Polg-Akita
mice (280 ± 50 mg/dL) had decreased still further compared with
their littermate Akita mice (475 ± 54 mg/dL), although they were
still significantly higher than in nondiabetic WT (167 ± 10 mg/
dL) and Polg mutant (151 ± 10 mg/dL) mice. The food intake of
the Polg-Akita mice was dramatically lower than that of litter-
mate Akita mice, and was no longer different from that of
nondiabetic mice. In contrast, the body weight of the Polg-Akita
mice increased steadily with age, and at 9 mo, they were signif-
icantly heavier than their Akita littermates (26.3 ± 1.2 g vs.
21.6 ± 1.2 g; P ≤ 0.01, Fig. 1C). The weight gain in the Polg-Akita
mice was associated with significantly larger amounts of s.c. and
visceral fat (Fig. 1D), although still below the amount observed
in WT mice. Diabetes in our female Akita mice was mild, as has
been reported (16); it was not affected by the PolgD257A mutation
(Fig. S2). Thus, plasma glucose levels are similar in Akita (276 ±
15 mg/dL) and Polg-Akita females (282 ± 20 mg/dL) through
9 mo of age. Likewise, food consumption is similar in Akita
(3.78 ± 0.16 g/d) and Polg-Akita females (3.71 ± 0.27 g/d)
through 9 mo of age. Together, these data show that, starting
≈3 mo of age, the PolgD257A mutation causes an age-dependent
and male-specific amelioration of the Akita diabetic phenotype.
Kidney Function. At 3 mo of age, Polg-Akita males had small but
significant decreases (≈20%) in water consumption (Fig. 2A) and
urine output (Fig. 2B) compared with Akita mice, although both
variables were markedly higher than in nondiabetic mice. Urine
glucose levels at 3 mo of age (Fig. 2C) were comparable in Polg-
Akita and Akita mice. However, as the hyperglycemia of the
male Polg-Akita mice improved with age, their water consump-
tion, urine output, and urinary glucose also declined and, at 9 mo
of age, they were no longer different from those of nondiabetic
mice. Urinary potassium, sodium, and chloride levels did not
differ in the diabetic mice regardless of the presence of the
PolgD257A mutation. Despite the improvement of hyperglycemia,
daily urinary albumin excretion was similar in the Polg-Akita and
Akita males although it was only modestly greater than in non-
diabetic males throughout the 9 mo of study (Fig. 2D).
The glomeruli showed no notable differences between the
diabetic Akita mice and the Polg-Akita mice under both light
microscopy (Fig. 2 E and F) or Electron microscopy (Fig. S3). No
evidence of fibrosis or areas of necrosis were found. In the distal
tubular epithelial cells, glycogen deposits in the central portion
of nuclei were present in both the Akita and Polg-Akita kidneys,
but were more prominent in the Akita mice than in Polg-Akita
mice (Fig. 2 E and F, long arrows). In the proximal tubular ep-
ithelial cells, in contrast, cytoplasmic clear foamy inclusions were
present only in the Polg-Akita kidneys (Fig. 2F, arrowheads),
whereas no such changes were seen in either the Akita kidneys or
in nondiabetic Polg kidneys of the same age. Ultrastructurally,
the foamy cytoplasmic inclusions seen by light microscopy in the
proximal tubular cells of the Polg-Akita kidneys proved to be
markedly enlarged lysosomes containing electron-dense material
and calcifications (Fig. 2H). Lamellated inclusions of glycolipids
in lysosomes are correlated with increased damage and turnover
of mitochondria within cells, and some inclusions can be seen in
Polg-Akita kidneys, although most of the mitochondria appeared
normal except for some variations in sizes and density. No
inclusions were seen in the Akita littermates (Fig. 2G). Taken
together, these data show that the distal renal tubular damage,
which occurs in the Akita mice in association with their severe
hyperglycemia, disappears in the Polg-Akita mice, in association
with their markedly decreased hyperglycemia, but proximal tu-
bular damage is now apparent because of mitochondrial damage
caused by the Polg mutation.
Fig. 1. Amelioration of diabetic profiles in Polg-Akita mice. Plasma glucose
(A), food consumption (B), and body weight (C) in male wild-type (W), Polg
(P), Akita (WA), and Polg-Akita (PA) mice. Gross weight of s.c. (SF) and vis-
ceral (VF) fat in 9-mo-old Akita (WA) and Polg-Akita (PA) male mice (D). All
data are represented as mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001
between Polg-Akita and Akita mice at each time point by the Student t test.
n ≥ 20, n ≥ 10, and n ≥ 7 at 3, 6, and 9 mo, respectively.
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Plasma Insulin and Insulin Sensitivity. Insulin mRNA amounts in
the pancreas of both Akita and Polg-Akita mice were similar, at
20–30% of the levels in nondiabetic wild-type mice (Fig. 3A).
Plasma insulin levels in the Akita and Polg-Akita mice were also
≈20% of those in nondiabetic mice. Plasma insulin levels in the
Polg-Akita mice were slightly higher than those in the Akita
littermates, but the difference was not significant (Fig. 3B). No
differences in the morphology and numbers of pancreatic islet
cells were found between the Akita (Fig. 3C) and Polg-Akita
(Fig. 3D) mice. At 9 mo, the Polg-Akita males exhibited impaired
clearance of oral glucose loads (Fig. 3E). However, plasma insulin
levels after the oral glucose challenge did not differ significantly
in the Akita and Polg-Akita mice (Fig. 3F). Taken together, these
data demonstrate that adding the PolgD257A mutation did not
significantly change the already impaired β-cell function of the
Akita mice, and that the impaired glucose handling exhibited by
the Akita mice was likewise not changed by the Polg mutation.
Small Intestine Function. In agreement with a previous report (11),
we find that the PolgD257A mutation causes an increase in apo-
ptosis within the villi of the small intestine of the Polg-Akita mice
relative to Akita mice. Additionally, we find an increase in ap-
optosis and a decrease in cell proliferation in the small intestine
crypts of the Polg-Akita mice relative to Akita mice (Fig. S4).
However, these profiles were found at similar levels in non-
diabetic Polg mice, indicating that these PolgD257A effects were
not altered by diabetes. In agreement with this result, the gross
morphology of the small intestine remained unchanged in 9-mo-
old Polg-Akita mice relative to Akita mice. The mRNA levels of
intestinal transporters that affect glucose uptake were also sim-
ilar in the Polg-Akita and Akita mice (Table S2). Pancreatic
expression of mRNAs for amylase, trypsinogen, chymotrypsino-
gen, and lipase in 9-mo-old Polg-Akita mice was not significantly
affected by the PolgD257A mutation (Fig. S4). Taken together,
these observations show that the Polg-Akita mice at 9 mo of age
display no significant indications of digestive problems or nutri-
ent malabsorption that might account for the amelioration of
their diabetic hyperphagia and hyperglycemia.
Appetite Control. Prompted by the decrease in food consumption
that developed in the Polg-Akita mice as they aged, we measured
two known regulators of appetite: leptin (a suppressor of appe-
tite) and ghrelin (a stimulator of appetite). At 9 mo of age, the
plasma leptin levels in Polg-Akita mice were significantly higher
(Fig. 4A), whereas circulating ghrelin levels were significantly
lower, relative to Akita littermates (Fig. 4B). Expression in the
hypothalamus of the anorexic gene, Pomc (coding for proopio-
melanocortin), and the orexic gene, Npy (coding for Neuropep-
tide Y), are critical for controlling appetite (20), and we found
that hypothalamic expression of the orexic Npy gene was signif-
icantly increased in Akita diabetic mice relative to nondiabetic
wild-type mice (Fig. 4C), whereas expression of the anorexic
Pomc gene was significantly decreased (Fig. 4D). However, in the
Polg-Akita mice, these diabetes-associated shifts in Npy and
Pomc expression were reversed, returning to levels not signifi-
cantly different from those in nondiabetic wild-type mice. Thus,
adding the PolgD257A mutation to the Akita mutation increases
Fig. 2. Renal function and histology in 9-mo-old Polg-Akita mice. Water consumption (A), urine output (B), urine glucose (C), and urinary albumin (D) in wild-
type (W), Polg (P), Akita (WA), and Polg-Akita (PA) mice. Renal histology of diabetic Akita (E) and Polg-Akita (F) mice with proximal tubules (blue outline) and
distal tubules (yellow outline). (G) Electron micrograph of Akita distal tubular cells with glycogen deposits (yellow arrowheads) within the nuclei. (H) Electron
micrograph Polg-Akita proximal tubular cells with mitochondria and lamellated inclusions (blue arrowheads) in the cytoplasm. All data are represented as
mean ± SEM. *P < 0.05 and ***P < 0.001 between Polg-Akita and Akita mice at each time point by the Student t test. n ≥ 6 at 3, 6, and 9 mo.
Fig. 3. Insulin levels in Polg-Akita and Akita mice. Insulin mRNA levels (A)
and plasma insulin (B) in wild-type (W), Akita (WA), and Polg-Akita (PA) mice
at 6 and 9 mo of age. All data are represented as mean ± SEM Pancreas
(H&E) from 9-mo-old Akita (C) and Polg-Akita (D) mice. Glucose tolerance
test (GTT) (E) and plasma insulin (F) during GTT at 9 mo of age in W, WA, and
PA. **P < 0.01 between Polg-Akita and Akita, ***P < 0.001 compared with
wild type by the Student t test.











plasma leptin, decreases plasma ghrelin, decreases hypothalamic
expression of Npy, and increases hypothalamic expression of
Pomc. It is likely that these changes in modulators of food intake,
all known to suppress appetite, result in the decreased appetite
we observed in Polg-Akita mice relative to Akita mice.
Testicular Function. The testis is severely affected by the PolgD257A
mutation (11), but not by diabetes. Thus, light microscopy
showed that the testes of our 9-mo-old Akita mice (Fig. 5C) were
not notably different from those of nondiabetic wild-type mice
(Fig. 5A). In contrast, the seminiferous tubules of the Polg (Fig.
5B) and Polg-Akita (Fig. 5D) mice were severely atrophic and
contained vacuoles. Marked loss of germ cells and spermato-
genesis was evident within the seminiferous tubules of both Polg
and Polg-Akita mice. Light microscopy showed a significant in-
crease in the number of Leydig cells per cluster in the Polg mice
relative to WT and in the Polg-Akita mice relative to Akita, al-
though the increase was less in the diabetic mice (Fig. 5E). Ul-
trastructurally, Leydig cells of the testis in Polg-Akita mice have
a markedly degenerative morphology compared with Akita mice,
including the presence of lipofuscin indicative of mitochondrial
damage (Fig. S5).
Plasma testosterone in wild-type mice at 9 mo of age was 220 ±
12 ng/dL. Plasma testosterone in the Akita mice was not de-
monstrably different from this value at 6 mo age, but had de-
creased to ≈50 ng/dL at 9 mo of age (Fig. 5F). The Polg-Akita
mice had significantly lower plasma testosterone levels than the
Akita mice at both ages (≈30%; P < 0.01). Together, these data
demonstrate that the PolgD257A mutation has a strong and direct
negative impact on testosterone levels and testicular function in
the Polg-Akita mice.
Testosterone Replacement.To test whether decreased testosterone
levels are responsible for the reduced appetite and hyperglyce-
mia, we implanted pellets into 6-mo-old Polg-Akita mice (n = 3)
that deliver the physiological dose of testosterone (0.14 mg/d)
commonly used in replacement therapy in mice (21). Within 15 d
after implantation of the testosterone pellet, plasma glucose in
the Polg-Akita mice increased from 300 mg/dL to 500 mg/dL,
indistinguishable from the level in Akita mice without testos-
terone supplementation (Fig. 6A). Their food consumption also
increased compared with untreated Polg-Akita mice and were
essentially the same level as in untreated Akita mice (Fig. 6B).
Taken together, these data show that testosterone is a key com-
ponent that directly regulates food consumption and, thereby,
influences the hyperglycemia of Akita male mice. Surprisingly,
however, despite the return of hyperglycemia in the Polg-Akita
mice treated with testosterone, their daily urine output, glucose
excretion, and urine albumin excretion were not increased (Fig. 6
C–E). This result indicates that the testosterone-treated Polg-
Akita mice are reabsorbing substantial amounts of glucose and
suggested to us that the kidneys of these animals were likely to be
metabolically stressed. In support of this idea, we found that the
ultrastructure of the proximal tubules of the Polg-Akita mice
treated with testosterone for 3 mo showed considerably more
lamellated inclusions (Fig. S3) than were present in the untreated
Polg-Akita mice of the same age (Fig. 2H).
Discussion
Because of the importance of mitochondria in metabolism, we
expected that the PolgD257A mutation, which leads to an accu-
Fig. 4. Appetite. Plasma leptin (A), plasma ghrelin (B), and hypothalamic
gene expression of Neuropeptide Y (C) and Proopiomelanocortin (D) in wild-
type (W), Akita (WA), and Polg-Akita (PA) mice at 9 mo of age. All data are
represented as mean ± SEM. *P < 0.05 and ***P < 0.001 indicate significant
difference by the Student t test.
Fig. 5. Diminished testis function in Polg-Akita mice. Comparable histology
sections of the testis of 9-mo-old wild-type (W; A) Polg (P; B), Akita (WA; C),
and Polg-Akita (PA; D) mice. Total number of cells per Leydig cluster (E)
and plasma testosterone (F). All data are represented as mean ± SEM. *P <
0.05, **P < 0.01, and ***P < 0.001 indicate significant difference by the
Student t test.
Fig. 6. Testosterone replacement in Polg-Akita mice. (A) Plasma glucose
levels in testosterone-implanted Akita (WA+T) and Polg-Akita (PA+T) mice
and Control Akita (WA or WA-T) and Polg-Akita (PA or PA-T). Food con-
sumption (B), urine volume (C), urine albumin (D), and urine glucose (E) in
WA, PA, and PA-T at 22 d after implant. All data are represented as mean ±
SEM. (Scale bar: 100 μm.) *P < 0.05, **P < 0.01, and ***P < 0.001 indicate
significant difference by the Student t test.
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mulation of random mtDNA mutations, would exacerbate the
diabetes exhibited by male Akita mice and would increase the
severity of their diabetic complications. Surprisingly, we found
the opposite result: a dramatic improvement of diabetic symp-
toms (hyperglycemia, food consumption, and water consump-
tion) in the Polg-Akita male mice as they aged. Accompanying
these changes, we found alterations in the expression of anorexic
(Pomc) and orexic (Npy) genes in the hypothalamus, indicating
that the Polg mutation had caused appetite suppression. We did
not find any improvement in the overall function of either the
pancreas or small intestine that would be sufficient to alter the
diabetes so markedly. However, there was a dramatic aging-as-
sociated increase in testicular damage in the Polg-Akita mice
relative to the Akita mice, including damage to the Leydig cells,
and a reduction in plasma testosterone. Testosterone replace-
ment increased food consumption in the double mutants, and
their hyperglycemia returned, confirming the influence of tes-
tosterone and appetite in the development of the diabetic symp-
toms of Akita male mice.
In nondiabetic animals, an increase in plasma glucose after
a meal stimulates the release of insulin. Insulin binds to insulin
receptors in peripheral tissues and triggers glucose uptake via
insulin-sensitive glucose transporters. Insulin, together with the
amylin released by the β-cells simultaneously with insulin (22),
plays an important role in the regulation of appetite by sup-
pressing orexic genes within the hypothalamus (23, 24). In Akita
mice, misfolded insulin protein causes ER stress and β-cell
death, resulting in reduced insulin production (13). Insufficient
insulin production initiates two pathways that accelerate hyper-
glycemia in Akita mice (Fig. S6A). First, it reduces the ability of
peripheral tissues to take up glucose. Second, the reduced insulin
impairs appetite suppression in the hypothalamus causing hy-
perphagia. The increased food intake induces an increased de-
mand for insulin, which increases the problems of the already
stressed insulin-producing β-cells leading to further β-cell death.
This damaging feedback can be partly interrupted by reducing
food intake, as illustrated by the well-documented benefits of
reduced food intake in the management of type 1 diabetes before
the discovery of insulin (25).
In the present study, we have demonstrated that the mtDNA
mutator, Polg-D257A, can break the self-induced cycle of hy-
perglycemia and hyperphagia of Akita male mice as they age
(Fig. S6B). The most striking age-dependent damage in the Polg-
Akita males is in the testis, accompanied with a decrease in
circulating testosterone. Recent studies have suggested that ag-
ing-related reduction of food consumption may in part result
from reduced testosterone and a consequent increase in leptin
production (26). Epidemiological studies have also demon-
strated an association between these factors (27). In addition,
testosterone administration has been shown to suppress the el-
evated leptin levels in older hypogonadal men (28, 29), and
dihydrotestosterone suppresses both leptin mRNA levels and
leptin secretions in adipocytes in vitro (30). Leptin, produced in
adipose tissues, is crucial in the regulation of appetite by sig-
naling through the hypothalamus (31). Our observations in aged
Polg-Akita males show the involvement of these factors in the
changes in food consumption and appetite induced by the Polg
mutation. Thus, as they age, Polg-Akita mice develop significant
increases in plasma leptin, increased Pomc, and decreased Npy
gene expression compared with Akita males. Furthermore, both
hyperglycemia and hyperphagia returned in Polg-Akita males
after testosterone administration. We conclude that the age-
dependent decline of testis function and testosterone production
caused by PolgD257A underlies the reduced diabetic phenotypes
of the Polg-Akita mice. This interpretation is supported by a re-
cent report that gonadectomy causes a marked reduction of
hyperglycemia in diabetic Akita males and normalizes Pomc
and Npy mRNA levels within their hypothalamus, and that re-
ducing the food intake of Akita mice also reduces their hyper-
glycemia (20).
Testosterone increases appetite in castrated rats and appears to
do so independently of its conversion to estrogen (32). Whether
testosterone acts on adipocytes to regulate production of leptin,
circulating leptin, or directly on the genes in the hypothalamus
remains to be elucidated. In addition, because plasma testoster-
one levels also declined in aged diabetic Akita mice without ap-
parent loss of appetite, other factors must be also involved. For
example, a significant reduction in circulating ghrelin works in
unison with the testosterone-leptin mechanism to reduce appe-
tite. We also note that this aging-related amelioration of diabetes
caused by the PolgD257A mutation could be exaggerated in the
Akita model of diabetes in which β-cell destruction is directly tied
to insulin production. Whether it is applicable to other animal
models of diabetes remains to be determined.
The nephropathy in our experimental diabetic Akita mice was
mild, in part because of their C57BL/6J genetic background,
which confers resistance to diabetic nephropathy (33, 34). Con-
cordant with the dramatic improvement of hyperglycemia and
reduced urine output, the Polg-Akita mice no longer had gly-
cogen deposits in the nuclei of their distal tubular cells. Instead,
despite the lessening of their hyperglycemia, the Polg-Akita mice
now had abnormalities in their proximal tubular cells. Formation
of enlarged lysosomes filled with lamellated inclusions and cal-
cifications indicate that the increase in mtDNA mutations in-
duced by the PolgD257Amutation leads to increased mitochondrial
destruction in the proximal tubular cells that have high-energy
requirements and are highly packed with mitochondria. We note
that diabetes is necessary to cause the observed abnormalities in
the proximal tubular epithelial cells, because they were not
present either in nondiabetic Polg males or in mildly diabetic
Polg-Akita females of the same age. Our observation that the
urine volumes and glucose excretion of testosterone-treated Polg-
Akita mice remained low, despite a return of hyperglycemia,
further emphasizes this interaction. Thus, the treated mice are
reabsorbing sufficient amounts of filtered glucose to avoid os-
motic diuresis and glycosuria even with plasma glucose levels
exceeding 500 mg/dL, which requires a large amount of energy.
Accompanying this high energy demand, we find an accumulation
of laminated bodies in the proximal tubules of the testosterone-
treated hyperglycemic Polg-Akita mice exceeding that in the
euglycemic-untreated Polg-Akita mice.
In conclusion, we have demonstrated that the mtDNA editing
mutation, PolgD257A, causes an age-dependent reduction of the
diabetic phenotype of Akita male mice. We have shown that this
reduction is, at least in part, due to appetite suppression caused
by a premature decline in testosterone production associated
with increased damage to Leydig cells. Because female Akita
and Polg-Akita mice are both only moderately hyperglycemic
and their food consumption remains similar throughout 9 mo of
age, the Polg-D257A does not affect the severity of their di-
abetes. The accumulation of mitochondrial debris in the proxi-
mal tubules of the Polg-Akita males, even when euglycemic,
demonstrates clearly that increased mutations in mtDNA exac-
erbate the kidney pathology in untreated type 1 diabetes.
Methods
Mice. All mice were maintained on normal chow containing 5.3% fat and
0.019% cholesterol (Prolab Isopro RMH 3000, ref 5P76; Agway). The exper-
imental animals were Akita heterozygous males homozygous for the
PolgD257A mutation. Controls were male Akita littermates that were either
wild type at the Polg locus (Polg+/+Akita) or heterozygous for the mutation
(PolgD257A/+Akita). Heterozygous PolgD257A mutants are phenotypically in-
distinguishable from wild-type mice (11). Both male and female animals
were monitored for diabetes and characterized at 3, 6, and 9 mo of age. The
breeding process to generate doubly mutant and control mice is described
in Fig. S7. All animal experiments were performed in accordance with the











Institutional Animal Care and Use Committee at the University of North
Carolina at Chapel Hill.
Plasma Analyses.Animals were fasted in themorning 4 h before the collection
of blood. Plasma glucose was measured by using a colorimetric kit (439–
90901; Wako Chemical). Plasma levels of leptin, insulin, and ghrelin were
measured by using ELISA kits (90030 and 90080; Crystal Chem and EZRGRT-
91K; LINCO Research). Testosterone levels were measured in plasma pooled
from 3 mice per sample with RIA kits (TKTT2; Siemens Medical Solutions
Diagnostics) by the Reproductive Biology Core at the University of Virginia.
Mitochondrial DNAMutations.Mitochondria was isolated from 200mg of liver
samples pooled from 3 to 5 mice of each genotype by differential centri-
fugation in a sucrose gradient as described (35). DNA was purified by using
standard isolation protocols and fragmented by Covaris S220 adaptive fo-
cused acoustic apparatus into 300 bp in length, and subjected to high
throughput sequencing of 5,000–27,000 reads per base by using Illumina
GAII. DNA sequence was processed through the bandled Solexa image ex-
traction pipeline and aligned with ELAND software against murine mito-
chondrial genome sequence (NCBL Build 36) as a reference. Default quality
score was adjusted to allow 2 mismatches per 36 bp reads. The uniquely
mapped reads were used for further analyses.
Gene Expression. Total RNA was purified from hypothalamus and pancreas
samples by using TRIzol (15596–026; Invitrogen) as described (36). Total
RNA from other tissues was purified by using an Automated Nucleic Acid
Workstation ABI 6700. Real-time PCR was performed in an ABI PRISM
7700 Sequence Detector (Applied Biosystems). β-Actin mRNA was used for
normalization.
Glucose Tolerance Tests. Male mice of each genotype were fasted for 4 h
before oral gavage of glucose (2 g/kg of body weight). Plasma was collected
for glucose measurement at time points of 0, 15, 30, 60, and 120 min
after gavage.
Urine Analyses.Mice were housed in metabolic cages, allowed to acclimate to
the new environment for 24 h, and urine samples were collected over
a second period of 24 h. Body weight, food, andwater weremeasured before
and at the end of the second period of 24 h. Urinary Albumin and creatinine
were measured by using kits (Albuwell, 1011 and Creatinine Companion,
1012; Exocell). Urinary levels of Na, K, and Cl were measured by using an
Automatic Chemical Analyzer (VT250; Johnson & Johnson).
Histology. Tissues were fixed in 4%paraformaldehyde (PFA). Paraffin sections
at 5 μm were stained with Hematoxylin and Eosin, Periodic acid-Schiff, or
Masson’s Trichrome. For transmission electron microscopy (JOEL USA), small
tissue fragments were postfixed in 2% osmium tetroxide and 1-μm-thick
sections were stained with uranyl acetate followed by lead citrate.
Testosterone Replacement. Six-month-old Polg-Akita and Akita mice were
implanted with 12.5 mg/90-day testosterone time-release pellet (Innovative
Research America). This dose was shown to normalize plasma testosterone
levels in orchidectomized mice (21).
Data Analysis. Values are reported as mean ± SEM. Statistical analyses were
conducted with JMP 6.0.2 software (SAS Institute). P values <0.05 were
considered significant.
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